Profile data is unavailable for this security.
About the company
Sensorion SA is a France-based company principally engaged in the biopharmaceutical sector. The Company is principally active in the development of targeted therapeutic solutions to treat inner ear diseases. The Company develops also drug treatments, from molecular biology all the way to animal pharmacology, toxicology, and clinical research and therapeutic solutions to treat vestibular deficits. Sensorion SA is a spin-off of the research team Pathophysiology and Therapy of Vestibular Deficits in Montpellier Neuroscience Institute.
- Revenue in EUR (TTM)0.00
- Net income in EUR-28.09m
- Incorporated2009
- Employees68.00
- LocationSensorion SA375, rue du Professeur Joseph BlayacMONTPELLIER 34080FranceFRA
- Phone+33 467207730
- Fax+33 499545884
- Websitehttps://www.sensorion-pharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fermentalg SA | 12.78m | -11.54m | 39.98m | 63.00 | -- | 1.41 | -- | 3.13 | -0.1242 | -0.1242 | 0.1353 | 0.3156 | 0.2472 | 7.91 | 3.29 | 199,734.40 | -17.09 | -18.10 | -21.17 | -20.59 | 20.94 | 25.51 | -69.14 | -147.66 | 1.83 | -- | 0.2368 | -- | 183.32 | 43.52 | 8.99 | -- | -4.91 | -- |
| Theranexus SA | 0.00 | -2.94m | 46.49m | 10.00 | -- | -- | -- | -- | -0.3641 | -0.3641 | 0.00 | -0.1923 | 0.00 | -- | -- | 0.00 | -66.82 | -44.47 | -148.89 | -50.85 | -- | -- | -- | -- | -- | -37.71 | 2.90 | -- | -- | -- | 74.15 | -- | -56.53 | -- |
| Eurofins Cerep SA | 40.46m | 7.15m | 80.20m | 207.00 | 11.21 | 1.12 | 8.38 | 1.98 | 1,418.43 | 1,418.43 | 8,027.24 | 14,234.14 | 0.4955 | 1.61 | 4.75 | 195,445.80 | 8.76 | 13.12 | 10.23 | 15.90 | 85.67 | 80.02 | 17.68 | 20.22 | 6.53 | -- | 0.0046 | -- | -8.20 | 5.46 | -6.34 | 10.36 | -- | -- |
| Ose Immunotherapeutics SA | 2.22m | -34.84m | 96.82m | 68.00 | -- | 1.91 | -- | 43.63 | -1.59 | -1.59 | 0.1009 | 2.26 | 0.0181 | -- | 0.4821 | 34,671.88 | -28.42 | -7.66 | -33.45 | -9.27 | -- | -- | -1,569.85 | -26.10 | -- | -- | 0.4331 | -- | 3,646.52 | 26.31 | 262.78 | -- | -25.52 | -- |
| Abionyx Pharma SA | 4.33m | -4.60m | 120.74m | 51.00 | -- | 21.49 | -- | 27.91 | -0.1317 | -0.1317 | 0.1238 | 0.1582 | 0.3033 | 17.39 | 7.16 | 84,823.53 | -32.25 | -26.53 | -43.11 | -38.31 | 17.78 | 15.59 | -106.31 | -131.06 | 1.35 | -- | 0.4281 | -- | -1.92 | -- | -24.53 | -- | -- | -- |
| Adocia SA | 10.35m | -9.71m | 131.37m | 77.00 | -- | -- | -- | 12.69 | -0.5622 | -0.5622 | 0.6343 | -0.0338 | 0.4068 | -- | 2.55 | 134,428.60 | -38.16 | -47.62 | -184.08 | -104.50 | -- | -- | -93.83 | -331.17 | 1.12 | -14.58 | 1.06 | -- | 333.49 | 34.18 | 55.95 | -- | -35.29 | -- |
| Maat Pharma SA | 3.92m | -31.13m | 135.53m | 60.00 | -- | 14.01 | -- | 34.56 | -2.15 | -2.15 | 0.270 | 0.5141 | 0.0786 | 11.22 | 0.5785 | 65,366.67 | -62.39 | -41.51 | -90.20 | -51.87 | 61.68 | -- | -793.83 | -976.99 | 2.21 | -29.53 | 0.6346 | -- | 44.34 | -- | -46.59 | -- | 42.53 | -- |
| Innate Pharma SA | 6.00m | -46.05m | 137.24m | 181.00 | -- | 26.23 | -- | 22.87 | -0.5497 | -0.5497 | 0.0714 | 0.0558 | 0.0491 | -- | 15.81 | 33,149.17 | -37.68 | -13.19 | -52.10 | -17.17 | 49.52 | 91.15 | -767.52 | -88.46 | -- | -- | 0.8401 | -- | -75.68 | -28.80 | -553.51 | -- | -64.08 | -- |
| Sensorion SA | 0.00 | -28.09m | 186.93m | 68.00 | -- | 1.92 | -- | -- | -0.0931 | -0.0931 | 0.00 | 0.1895 | 0.00 | -- | -- | 0.00 | -32.12 | -34.53 | -38.36 | -43.50 | -- | -- | -- | -- | -- | -- | 0.0265 | -- | -- | -- | -17.72 | -- | 98.90 | -- |
| Eurobio Scientific SA | 162.09m | 2.36m | 240.85m | 380.00 | 100.17 | 1.30 | 13.52 | 1.49 | 0.2346 | 0.2346 | 15.76 | 18.03 | 0.5651 | 1.62 | 5.21 | 497,196.30 | 0.8231 | 14.00 | 1.02 | 17.37 | 23.69 | 51.40 | 1.46 | 20.70 | 1.25 | 1.72 | 0.0845 | 0.00 | 18.89 | 21.21 | -17.31 | 4.86 | 15.38 | -- |
| Transgene SA | 7.24m | -36.78m | 244.03m | 147.00 | -- | -- | -- | 33.71 | -0.1456 | -0.1456 | 0.0618 | -0.0272 | 0.1578 | -- | 8.72 | 43,872.73 | -80.19 | -33.32 | -186.71 | -40.55 | -- | -- | -508.10 | -251.37 | -- | -17.28 | 1.13 | -- | -20.34 | -14.48 | -52.15 | -- | 12.68 | -- |
| Cellectis SA | 69.88m | -29.93m | 248.03m | 224.00 | -- | 2.93 | -- | 3.55 | -0.2984 | -0.2984 | 0.6947 | 1.18 | 0.2234 | -- | 8.58 | 311,972.80 | -9.57 | -21.50 | -16.65 | -29.24 | -- | -32.79 | -42.82 | -220.86 | -- | -3.13 | 0.5013 | -- | 435.37 | 16.44 | 66.41 | -- | -21.58 | -- |
| Genfit SA | 45.41m | -38.76m | 449.58m | 188.00 | -- | 8.56 | -- | 9.90 | -0.7737 | -0.7737 | 0.9083 | 1.05 | 0.2207 | 519.75 | 0.9236 | 252,277.80 | -18.84 | -7.73 | -23.25 | -9.79 | 95.42 | 95.68 | -85.35 | -37.15 | 3.74 | -10.87 | 0.1223 | -- | 85.82 | 11.61 | 105.22 | -- | -13.57 | -- |
Data as of Mar 02 2026. Currency figures normalised to Sensorion SA's reporting currency: Euro EUR
32.14%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Redmile Group LLCas of 31 Dec 2024 | 66.05m | 21.97% |
| Fidelity Management & Research Co. LLCas of 31 Dec 2025 | 18.15m | 6.04% |
| T. Rowe Price Associates, Inc. (IM)as of 31 Dec 2025 | 11.67m | 3.88% |
| Simplify Asset Management, Inc.as of 06 Feb 2026 | 515.55k | 0.17% |
| Equitable Investment Management Group LLCas of 30 Sep 2025 | 125.89k | 0.04% |
| Gestys SAas of 30 Jan 2026 | 100.00k | 0.03% |
More ▼
Data from 31 Dec 2025 - 30 Jan 2026Source: FactSet Research Systems Inc.
